# Liu Wenyi

> Liu Wenyi is a Series B investor at Apricot Capital backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Apricot Capital](https://shizune.co/investors/profile/apricot-capital-ceb8)
- Total investments: 2
- Last investment: Aug 2020
- Lead investor: 100%
- Last updated: Aug 2026

Liu Wenyi is a founding partner of Apricot Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Biotechnology | 2 | 100% |
| Genetics | 1 | 50% |
| Manufacturing | 1 | 50% |
| Pharmaceutical | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Funding Round | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 1 | 50% |
| Hong Kong | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Jabrehoo Med Tech | Jabrehoo focusing on clinical transformation and innovative research and development of related products in the field of assisted reproduction, genetics and eugenics, providing one-stop solutions for reproductive genetics for assisted reproduction couples, infertile patients, and people who are preparing for pregnancy, and promoting thelocalization of various detections. | $14.2M | Series B | Aug 10, 2020 |  |
| SinoMab Bioscience | SinoMab Bioscience is a biopharmaceutical company. They develop therapeutic antibodies for the treatment of life-threatening diseases. They treat rheumatoid arthritis, immunological diseases, and systemic lupus erythematosus. |  |  | Feb 19, 2019 |  |

2 of 2 investments shown.

## Co-investors
- [CICC Capital](https://shizune.co/investors/profile/cicc-capital) — VC Fund, 1 deal together

## About Apricot Capital

VC Fund · Shanghai, China

Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.

5 contacts available at Apricot Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Arthur Qiang | Managing Partner | https://shizune.co/investors/profile/arthur-qiang |
| Haigang Chen | Managing Partner | https://shizune.co/investors/profile/haigang-chen-a7ec |
| Liu Wenyi | Co-Founding Partner | https://shizune.co/investors/profile/liu-wenyi |
| Weixiong Mao | Founding Partner | https://shizune.co/investors/profile/weixiong-mao |
| Zhen Zhang | Managing Director | https://shizune.co/investors/profile/zhen-zhang-b058 |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Liu Wenyi invest in?

Liu Wenyi invests primarily in Health Care, Biotechnology and Genetics startups, most often at Series B and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Liu Wenyi last invest?

The most recent investment recorded for Liu Wenyi closed in Aug 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co